Abstract
Abstract The pharmacokinetic conditions for oral administration of 5‐fluorouracil (5‐FU) were investigated in 16 patients with malignant liver tumours. The concentration of 5‐FU in portal and systemic blood was determined by a microbiologic method every 10 min. during 2 hours after oral or intravenous administration of a standard dose of 250 mg 5‐FU (∼ 4 mg/kg b.wt.) or 15 mg 5‐FU/kg b.wt. The drug was rapidly absorbed after oral administration with peak values within 10–30 min. 25% of the lower and 40% of the higher oral dose reached the systemic circulation. The reduction of systemic bio‐availability was partly accomplished by a loss in the gastrointestinal tract and partly by extraction by the liver. The hepatic extraction ratio was calculated to 0.56 and 0.26 after the lower and the higher dose respectively indicating a saturable process. The availability of 5‐FU was significantly higher in portal blood than in systemic blood after oral administration. The opposite conditions were found after intravenous administration. Thus, oral administration of 5‐FU to patients with malignant liver tumours seems rational.
References
30
Referenced
35
{'key': 'e_1_2_2_2_1', 'first-page': '589', 'article-title': 'The blood supply of experimental liver metastases. IV. Changes of vascularily with increasing tumor growth', 'volume': '75', 'author': 'Ackerman N. B.', 'year': '1974', 'journal-title': 'Surgery'}
/ Surgery / The blood supply of experimental liver metastases. IV. Changes of vascularily with increasing tumor growth by Ackerman N. B. (1974){'key': 'e_1_2_2_3_1', 'first-page': '131', 'article-title': 'Results of liver dearterialization combined with regional perfusion of 5‐Fluorouracil for liver cancer', 'volume': '142', 'author': 'Almersjö O.', 'year': '1976', 'journal-title': 'Acta Chir. Scand.'}
/ Acta Chir. Scand. / Results of liver dearterialization combined with regional perfusion of 5‐Fluorouracil for liver cancer by Almersjö O. (1976)10.1159/000127895
{'key': 'e_1_2_2_5_1', 'first-page': '27', 'article-title': 'Results of regional portal infusion of 5‐fluorouracil to patients with primary and secondary liver cancer', 'volume': '65', 'author': 'Almersjö O.', 'year': '1976', 'journal-title': 'Ann. Chir. Gynaecol. Fenn.'}
/ Ann. Chir. Gynaecol. Fenn. / Results of regional portal infusion of 5‐fluorouracil to patients with primary and secondary liver cancer by Almersjö O. (1976){'key': 'e_1_2_2_6_1', 'first-page': '227', 'article-title': 'Methodological aspects on an agar plate technique for determination of biologically active 5‐fluorouracil in blood, urine and bile', 'volume': '85', 'author': 'Almersjö O.', 'year': '1977', 'journal-title': 'Acta Pathol. Microbiol. Scand.'}
/ Acta Pathol. Microbiol. Scand. / Methodological aspects on an agar plate technique for determination of biologically active 5‐fluorouracil in blood, urine and bile by Almersjö O. (1977)10.1001/jama.1964.03070200122030
10.1002/1097-0142(197512)36:6<2413::AID-CNCR2820360621>3.0.CO;2-3
10.1002/1097-0142(1971)28:4<907::AID-CNCR2820280414>3.0.CO;2-9
10.1002/1097-0142(196901)23:1<198::AID-CNCR2820230126>3.0.CO;2-J
10.1002/1097-0142(197401)33:1<14::AID-CNCR2820330106>3.0.CO;2-3
{'key': 'e_1_2_2_12_1', 'first-page': '1045', 'article-title': 'The physiological disposition of 5‐fluorouracil in mice bearing SOL Li210 lymphocytic leukemia', 'volume': '32', 'author': 'Chadwick M.', 'year': '1972', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / The physiological disposition of 5‐fluorouracil in mice bearing SOL Li210 lymphocytic leukemia by Chadwick M. (1972){'key': 'e_1_2_2_13_1', 'first-page': '845', 'article-title': 'Comparative physiological dispositions of 5‐fluoro‐2′‐deoxyuridine and 5‐fluorouracil in mice bearing solid L1210 lymphocytic leukemia', 'volume': '60', 'author': 'Chadwick M.', 'year': '1976', 'journal-title': 'Cancer Treatment Reports'}
/ Cancer Treatment Reports / Comparative physiological dispositions of 5‐fluoro‐2′‐deoxyuridine and 5‐fluorouracil in mice bearing solid L1210 lymphocytic leukemia by Chadwick M. (1976)10.1002/cpt196455581
{'key': 'e_1_2_2_15_1', 'first-page': '723', 'article-title': 'Clinical pharmacology of oral and intravenous 5‐flurorouracil (NSG‐19893)', 'volume': '58', 'author': 'Cohen J. L.', 'year': '1974', 'journal-title': 'Cancer Chemother. Rep.'}
/ Cancer Chemother. Rep. / Clinical pharmacology of oral and intravenous 5‐flurorouracil (NSG‐19893) by Cohen J. L. (1974)10.1001/archderm.1965.01600160066015
/ Arch. Dermatol. / Futher studies with topical 5‐fluorouracil by Dillaha J. (1965){'key': 'e_1_2_2_17_1', 'first-page': '3784', 'article-title': 'A clinical — pharmacologic evaluation of hepatic arteriar infusions of 5‐fluoro‐2′‐deoxyuridine and 5‐fluorouracil', 'volume': '38', 'author': 'Ensminger W. P.', 'year': '1978', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / A clinical — pharmacologic evaluation of hepatic arteriar infusions of 5‐fluoro‐2′‐deoxyuridine and 5‐fluorouracil by Ensminger W. P. (1978){'key': 'e_1_2_2_18_1', 'first-page': '279', 'article-title': 'Determination of 5‐fluorouracil (NSC‐19893) plasma levels in rats at man by isotope dilution‐mass fragmentography', 'volume': '59', 'author': 'Finn C.', 'year': '1975', 'journal-title': 'Cancer Chemother. Rep. (Part I)'}
/ Cancer Chemother. Rep. (Part I) / Determination of 5‐fluorouracil (NSC‐19893) plasma levels in rats at man by isotope dilution‐mass fragmentography by Finn C. (1975)10.1002/jps.2600661019
{'key': 'e_1_2_2_20_1', 'volume-title': 'Pharmacokinetics', 'author': 'Gibaldi M.', 'year': '1975'}
/ Pharmacokinetics by Gibaldi M. (1975)10.1007/978-3-642-65806-8_12
10.1038/bjc.1978.278
10.1056/NEJM197301252880408
10.1002/1097-0142(1971)28:4<902::AID-CNCR2820280413>3.0.CO;2-R
{'key': 'e_1_2_2_25_1', 'first-page': '3479', 'article-title': 'Pharmacokinetics of fluorouracil in humans', 'volume': '38', 'author': 'Millan W. E.', 'year': '1978', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Pharmacokinetics of fluorouracil in humans by Millan W. E. (1978){'key': 'e_1_2_2_26_1', 'first-page': '1109', 'article-title': 'Question and answers: Oral vs intravenous administration of fluorouracil', 'volume': '229', 'author': 'Moertel C. G.', 'year': '1974', 'journal-title': 'JAMA'}
/ JAMA / Question and answers: Oral vs intravenous administration of fluorouracil by Moertel C. G. (1974){'key': 'e_1_2_2_27_1', 'first-page': '49', 'article-title': 'Studies on fluorinated pyrimidines XVI. Metabolism of 5‐fluorouracil‐2‐C14 and 5‐fluoro‐2′‐deoxyuridine‐2‐C14 in cancer patients', 'volume': '23', 'author': 'Mukherjee K. L.', 'year': '1963', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Studies on fluorinated pyrimidines XVI. Metabolism of 5‐fluorouracil‐2‐C14 and 5‐fluoro‐2′‐deoxyuridine‐2‐C14 in cancer patients by Mukherjee K. L. (1963)10.1016/S0305-7372(76)80021-7
10.2165/00003088-197702060-00004
{'key': 'e_1_2_2_30_1', 'first-page': '749', 'article-title': 'The blood supply of colorectal liver metastases', 'volume': '39', 'author': 'Taylor J.', 'year': '1979', 'journal-title': 'Brit. J. Cancer'}
/ Brit. J. Cancer / The blood supply of colorectal liver metastases by Taylor J. (1979)10.1016/S0065-2571(71)80038-9
Dates
Type | When |
---|---|
Created | 15 years, 1 month ago (July 29, 2010, 5:37 p.m.) |
Deposited | 1 year, 9 months ago (Nov. 7, 2023, 4:55 p.m.) |
Indexed | 1 year, 6 months ago (Feb. 6, 2024, 7:48 a.m.) |
Issued | 45 years, 3 months ago (May 1, 1980) |
Published | 45 years, 3 months ago (May 1, 1980) |
Published Online | 16 years, 5 months ago (March 13, 2009) |
Published Print | 45 years, 3 months ago (May 1, 1980) |
@article{Almersj__1980, title={Pharmacokinetic Studies of 5‐Fluorouracil after Oral and Intravenous Administration in Man}, volume={46}, ISSN={0001-6683}, url={http://dx.doi.org/10.1111/j.1600-0773.1980.tb02463.x}, DOI={10.1111/j.1600-0773.1980.tb02463.x}, number={5}, journal={Acta Pharmacologica et Toxicologica}, publisher={Wiley}, author={Almersjö, O. E. and Gustavsson, B. G. and Regårdh, C.‐G. and Wåhlén, P.}, year={1980}, month=may, pages={329–336} }